Minister of Health (Canada)

Minister of Health (Canada)
Moxy · CC BY-SA 4.0 · source
Post	Minister of Health
Body	Canada
Incumbent	Mark Holland
Incumbentsince	26 July 2023
Department	Health Canada
Style	The Honourable
Member of	Cabinet of Canada
Reports to	Prime Minister of Canada
Appointer	Governor General of Canada
Termlength	At Majesty's pleasure
Formation	1919
Inaugural	Honoré Mercier

Minister of Health (Canada) is a senior Cabinet of Canada position responsible for national public health, health policy, and the federal department charged with regulating health products and services. The officeholder leads Health Canada and coordinates with provincial and territorial counterparts such as the Ontario Ministry of Health, Quebec Ministry of Health and Social Services, and British Columbia Ministry of Health on pan-Canadian issues like pandemic response, pharmaceuticals, and health promotion. The minister interacts with international institutions including the World Health Organization, the Pan American Health Organization, and the Organisation for Economic Co-operation and Development on transnational health matters.

History

The portfolio traces roots to early 20th-century public health movements and statutes such as the 1919 creation of a federal health function following the 1918 influenza pandemic and the expansion of federal roles through wartime mobilization including interactions with the Department of Soldiers' Civil Re-establishment. Postwar developments linked the office to social policy debates exemplified by interactions with figures like Tommy Douglas, the introduction of medicare in Saskatchewan, and national negotiations culminating in the Canada Health Act of 1984. The role evolved through administrations of William Lyon Mackenzie King, John Diefenbaker, Pierre Trudeau, Brian Mulroney, Jean Chrétien, Paul Martin, Stephen Harper, Justin Trudeau, and others, reflecting shifting federal-provincial relations shaped by decisions such as transfers negotiated at meetings like the First Ministers' Conference. International crises including the HIV/AIDS pandemic, the 2003 SARS outbreak, and the COVID-19 pandemic further transformed ministerial responsibilities and institutional mandates.

Role and responsibilities

The minister oversees Health Canada and statutory agencies including the Public Health Agency of Canada, the Canadian Institutes of Health Research, and the Patented Medicine Prices Review Board. Responsibilities cover regulatory regimes such as the Food and Drugs Act and the Controlled Drugs and Substances Act insofar as federal jurisdiction allows, stewardship of programs like the Canada Health Transfer, engagement with provincial ministers (e.g., Minister of Health and Long-Term Care (Ontario), Minister of Health and Social Services (Québec)) at intergovernmental fora such as the Council of the Federation, and international negotiation with entities like the World Trade Organization on matters affecting pharmaceuticals. The minister advises the Prime Minister of Canada and participates in cabinet decision-making, emergency orders under the Quarantine Act, and appointment of senior officials to bodies such as the Canadian Food Inspection Agency and crown corporations like the Canadian Blood Services.

List of ministers

Prominent individuals who have held the portfolio include senators and MPs from parties like the Liberal Party of Canada, the Conservative Party of Canada, the New Democratic Party, and historical parties such as the Progressive Conservative Party of Canada. Notable officeholders include Monique Begin (example), Jane Philpott, Rona Ambrose, Tony Clement, Anne McLellan, Patty Hajdu, and Ginette Petitpas Taylor. The list spans from early 20th-century ministers who managed postwar public health to contemporary figures who navigated the COVID-19 pandemic and negotiated with stakeholders such as Canadian Nurses Association, Canadian Medical Association, and provincial health ministers.

Organizational structure and associated bodies

The minister directs a portfolio composed of departmental branches and arm's-length agencies including Health Canada, the Public Health Agency of Canada (PHA), the Canadian Institutes of Health Research (CIHR), the Patented Medicine Prices Review Board (PMPRB), and the Canadian Food Inspection Agency (CFIA) in related intersections. Statutory advisory committees such as the National Advisory Committee on Immunization, professional associations like the Canadian Medical Association, labour organizations such as the Canadian Labour Congress, and regulatory partners including the Royal College of Physicians and Surgeons of Canada engage with the minister. Interjurisdictional mechanisms include the Canada Health Transfer, bilateral provincial agreements (e.g., with Alberta Health Services), and collaborative initiatives with international partners like the Centers for Disease Control and Prevention and the European Medicines Agency.

Policy and major initiatives

Major initiatives driven or overseen by ministers have included implementation of the Canada Health Act principles, pharmacare debates linked to reports like the Romanow Report and the Hoskins Report, national immunization campaigns in partnership with the World Health Organization, opioid-response strategies responding to the Canadian opioid crisis, and emergency responses during the 2003 SARS outbreak and the COVID-19 pandemic. Other policy areas have included regulation of medical devices under the Food and Drugs Act, legalization and regulation frameworks informed by the Cannabis Act, strategies addressing chronic disease in collaboration with organizations such as the Heart and Stroke Foundation of Canada, and funding of health research via the Canadian Institutes of Health Research. Ministers have negotiated agreements with pharmaceutical companies, provincial premiers at First Ministers' Meetings, and international agencies such as the G7 and G20 on global health security.

Controversies and criticisms

Controversies have arisen over federal-provincial jurisdictional disputes epitomized by litigation under the Canada Health Act, debates over the scope of national pharmacare inspired by the Senate of Canada and panels like the Advisory Council on the Implementation of National Pharmacare, criticism from professional bodies including the Canadian Nurses Association and the Canadian Medical Association on staffing and funding, regulatory decisions involving the Patented Medicine Prices Review Board, procurement issues during the COVID-19 pandemic including dealings with suppliers, and transparency concerns tied to appointments and advisory contracts. Public inquiries such as commissions formed after the SARS Commission and commissions of inquiry have examined ministerial oversight, while judicial reviews and parliamentary committees like the House of Commons Standing Committee on Health have scrutinized policy choices and implementation.

Category:Government of Canada Category:Health in Canada